These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36564728)

  • 1. Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children.
    Fernandes M; Bassani D; Albernaz E; Bertoldi AD; Silveira MF; Matijsevich A; Anselmi L; Cruz S; Halal CS; Tovo-Rodrigues L; Cruz GIN; Metgud D; Santos IS
    BMC Pediatr; 2022 Dec; 22(1):733. PubMed ID: 36564728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the INTERGROWTH-21st Neurodevelopment Assessment (INTER-NDA) in 2 year-old children.
    Murray E; Fernandes M; Newton CRJ; Abubakar A; Kennedy SH; Villar J; Stein A
    PLoS One; 2018; 13(2):e0193406. PubMed ID: 29489865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INTERGROWTH-21st Project international INTER-NDA standards for child development at 2 years of age: an international prospective population-based study.
    Fernandes M; Villar J; Stein A; Staines Urias E; Garza C; Victora CG; Barros FC; Bertino E; Purwar M; Carvalho M; Giuliani F; Wulff K; Abubakar AA; Kihara M; Cheikh Ismail L; Aranzeta L; Albernaz E; Kunnawar N; Di Nicola P; Ochieng R; Sandells T; Savini S; Temple S; Murray E; Ohuma EO; Gravett MG; Pang R; Jaffer YA; Noble JA; Winsey A; Lambert A; Papageorghiou AT; Bhutta Z; Kennedy S
    BMJ Open; 2020 Jun; 10(6):e035258. PubMed ID: 32513882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASQ-3 and BSID-III's concurrent validity and predictive ability of cognitive outcome at 5 years.
    Duggan C; Irvine AD; O'B Hourihane J; Kiely ME; Murray DM
    Pediatr Res; 2023 Oct; 94(4):1465-1471. PubMed ID: 36841883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptation of the INTERGROWTH-21st neurodevelopment assessment (INTER-NDA) to the context of the English-speaking Caribbean.
    Waechter R; Evans R; Hanna S; Murray T; Mobley C; Holmes S; Isaac R; Wolfe R; Andrew E; Landon B; Fernandes M
    BMC Pediatr; 2022 Jan; 22(1):21. PubMed ID: 34983456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the Parent Report of Children's Abilities-Revised (PARCA-R) versus the Bayley Scales of Infant Development III.
    Martin AJ; Darlow BA; Salt A; Hague W; Sebastian L; McNeill N; Tarnow-Mordi W
    Arch Dis Child; 2013 Dec; 98(12):955-8. PubMed ID: 24030249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity, reliability, and transcultural adaptations of the Bayley Scales of Infant and Toddler Development (BSID-III-NL) for children in Suriname.
    McLester-Davis LWY; Shankar A; Kataria LA; Hidalgo AG; van Eer ED; Koendjbiharie AP; Ramjatan R; Hatch VI; Middleton MA; Zijlmans CWR; Lichtveld MY; Drury SS
    Early Hum Dev; 2021 Sep; 160():105416. PubMed ID: 34256311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability and Reliability of the Bayley Scales of Infant Development III Cognitive and Motor Scales among Children in Makwanpur.
    Manandhar SR; Dulal S; Manandhar DS; Saville N; Prost A
    J Nepal Health Res Counc; 2016 Jan; 14(32):47-50. PubMed ID: 27426711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interrater reliability of the Bayley III test in the Italian Northern-Adriatic Cohort II].
    Deroma L; Bin M; Tognin V; Rosolen V; Valent F; Barbone F; Carrozzi M
    Epidemiol Prev; 2013; 37(4-5):297-302. PubMed ID: 24293495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A psychometric study of the Bayley Scales of Infant and Toddler Development - 3rd Edition for term and preterm Taiwanese infants.
    Yu YT; Hsieh WS; Hsu CH; Chen LC; Lee WT; Chiu NC; Wu YC; Jeng SF
    Res Dev Disabil; 2013 Nov; 34(11):3875-83. PubMed ID: 24029804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability and Reliability of the Bayley Scales of Infant and Toddler Development-III Among Children in Bhaktapur, Nepal.
    Ranjitkar S; Kvestad I; Strand TA; Ulak M; Shrestha M; Chandyo RK; Shrestha L; Hysing M
    Front Psychol; 2018; 9():1265. PubMed ID: 30087639
    [No Abstract]   [Full Text] [Related]  

  • 13. Which Bayley-III cut-off values should be used in different developmental levels?
    Çelik P; Ayranci Sucakli I; Yakut HI
    Turk J Med Sci; 2020 Jun; 50(4):764-770. PubMed ID: 31905494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent validity of the ages and stages questionnaires with Bayley Scales of Infant Development-III at 2 years - Singapore cohort study.
    Agarwal PK; Xie H; Sathyapalan Rema AS; Meaney MJ; Godfrey KM; Rajadurai VS; Daniel LM
    Pediatr Neonatol; 2024 Jan; 65(1):48-54. PubMed ID: 37544806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodevelopment of HIV-exposed uninfected children in South Africa: outcomes from an observational birth cohort study.
    Wedderburn CJ; Yeung S; Rehman AM; Stadler JAM; Nhapi RT; Barnett W; Myer L; Gibb DM; Zar HJ; Stein DJ; Donald KA
    Lancet Child Adolesc Health; 2019 Nov; 3(11):803-813. PubMed ID: 31515160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Bayley-III scale may underestimate neurodevelopmental disability after cardiac surgery in infants.
    Goldstone AB; Baiocchi M; Wypij D; Stopp C; Andropoulos DB; Atallah J; Atz AM; Beca J; Donofrio MT; Duncan K; Ghanayem NS; Goldberg CS; Hövels-Gürich H; Ichida F; Jacobs JP; Justo R; Latal B; Li JS; Mahle WT; McQuillen PS; Menon SC; Pike NA; Pizarro C; Shekerdemian LS; Synnes A; Williams IA; Bellinger DC; Newburger J; Gaynor JW
    Eur J Cardiothorac Surg; 2020 Jan; 57(1):63-71. PubMed ID: 31006006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the Bayley-III to assess neurodevelopmental delay: which cut-off should be used?
    Johnson S; Moore T; Marlow N
    Pediatr Res; 2014 May; 75(5):670-4. PubMed ID: 24492622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of ASQ for screening of neurodevelopmental delays in low resource countries.
    Manasyan A; Salas AA; Nolen T; Chomba E; Mazariegos M; Tshefu Kitoto A; Saleem S; Naqvi F; Hambidge KM; Goco N; McClure EM; Wallander JL; Biasini FJ; Goldenberg RL; Bose CL; Koso-Thomas M; Krebs NF; Carlo WA
    BMJ Open; 2023 May; 13(5):e065076. PubMed ID: 37221030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, reliability and validity of a new measure of overall health for pre-school children.
    Saigal S; Rosenbaum P; Stoskopf B; Hoult L; Furlong W; Feeny D; Hagan R
    Qual Life Res; 2005 Feb; 14(1):243-57. PubMed ID: 15789958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Moderate and Late Preterm Birth and Neurodevelopment and Social-Emotional Development at Age 2 Years.
    Cheong JL; Doyle LW; Burnett AC; Lee KJ; Walsh JM; Potter CR; Treyvaud K; Thompson DK; Olsen JE; Anderson PJ; Spittle AJ
    JAMA Pediatr; 2017 Apr; 171(4):e164805. PubMed ID: 28152144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.